3Curado MPEB,Shin HR,Storm H,et al. Cancer Inci- dence in Five Continents,Vol. IX [M] . Lyon: IARC Sci- entific Publication,2008. 1-837.
4Felay L, Burkhard C,Whe|an S,et al. Cheek and Conver- sion Programs for Cancer Registries. IARC Technical Re- port No.42[M]. Lyon : IARC, 2005.
5Bray F,Parkin DM. Evaluation of data quality in the can- cer registry:principles and methods. Part I :comparabili- ty, validity and timeliness [J]. Eur J Cancer, 2009,45 (5).. 747-755.
6Parkin DM,Chen VW,Ferlay J,et al. Comparability and Quality Control in Cancer Registration. |ARC Technical Report No.19[M]. Lyon:|ARC, 1994-.
7Felay J. The IARCcrgTools program[EB/OL], http://www.i- acr.com.fr/iarccrgtoo|s.htm.
8Allemani C,Weir HK,Carrira H,et al. Global surveil- lance of cancer survival 1995-2009 :analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)[J]. Lancet,2014, Nov 26.[Epub ahead of print].
9Zeng H,Zheng R,Guo Y,et al. Cancer survival in China, 2003-2005:a popuLation-based study [J]. lnt J Cancer, 2014,Sep20. [Epub ahead of print].
10Chen W,Zheng R,Zhang S,et al. Report of cancer inci- dence and mortality in China,2010 [J]. Ann Transl Med, 2014,2(7):61.
